vs
GRID DYNAMICS HOLDINGS, INC.（GDYN）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是GRID DYNAMICS HOLDINGS, INC.的2.0倍（$207.3M vs $104.1M），GRID DYNAMICS HOLDINGS, INC.净利率更高（-1.4% vs -62.0%，领先60.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 3.7%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 12.0%）
Escape Dynamics Inc.是一家总部位于科罗拉多州的科技企业，活跃于2010年至2015年，核心业务方向是研发可单级入轨、依靠电磁驱动的可重复使用航天飞机，并推动该项目实现商业化落地。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GDYN vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.1M | $207.3M |
| 净利润 | $-1.5M | $-128.6M |
| 毛利率 | 34.8% | — |
| 营业利润率 | 61.7% | -54.7% |
| 净利率 | -1.4% | -62.0% |
| 营收同比 | 3.7% | 25.9% |
| 净利润同比 | -150.6% | 3.5% |
| 每股收益（稀释后） | $-0.02 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $104.1M | — | ||
| Q4 25 | $106.2M | $207.3M | ||
| Q3 25 | $104.2M | $159.9M | ||
| Q2 25 | $101.1M | $166.5M | ||
| Q1 25 | $100.4M | $139.3M | ||
| Q4 24 | $100.3M | $164.6M | ||
| Q3 24 | $87.4M | $139.5M | ||
| Q2 24 | $83.0M | $147.0M |
| Q1 26 | $-1.5M | — | ||
| Q4 25 | $306.0K | $-128.6M | ||
| Q3 25 | $1.2M | $-180.4M | ||
| Q2 25 | $5.3M | $-115.0M | ||
| Q1 25 | $2.9M | $-151.1M | ||
| Q4 24 | $4.5M | $-133.2M | ||
| Q3 24 | $4.3M | $-133.5M | ||
| Q2 24 | $-817.0K | $-131.6M |
| Q1 26 | 34.8% | — | ||
| Q4 25 | 34.0% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 34.1% | — | ||
| Q1 25 | 36.8% | — | ||
| Q4 24 | 36.9% | — | ||
| Q3 24 | 37.4% | — | ||
| Q2 24 | 35.6% | — |
| Q1 26 | 61.7% | — | ||
| Q4 25 | 0.5% | -54.7% | ||
| Q3 25 | -0.2% | -106.9% | ||
| Q2 25 | -0.1% | -64.8% | ||
| Q1 25 | -2.0% | -102.6% | ||
| Q4 24 | 1.3% | -74.3% | ||
| Q3 24 | 2.4% | -94.6% | ||
| Q2 24 | 0.0% | -79.1% |
| Q1 26 | -1.4% | — | ||
| Q4 25 | 0.3% | -62.0% | ||
| Q3 25 | 1.1% | -112.8% | ||
| Q2 25 | 5.2% | -69.0% | ||
| Q1 25 | 2.9% | -108.5% | ||
| Q4 24 | 4.5% | -80.9% | ||
| Q3 24 | 4.9% | -95.7% | ||
| Q2 24 | -1.0% | -89.5% |
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.01 | $-1.28 | ||
| Q3 25 | $0.01 | $-1.81 | ||
| Q2 25 | $0.06 | $-1.17 | ||
| Q1 25 | $0.03 | $-1.57 | ||
| Q4 24 | $0.06 | $-1.34 | ||
| Q3 24 | $0.05 | $-1.40 | ||
| Q2 24 | $-0.01 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $327.5M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $530.1M | $-80.0M |
| 总资产 | $605.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $327.5M | — | ||
| Q4 25 | $342.1M | $421.0M | ||
| Q3 25 | $338.6M | $202.5M | ||
| Q2 25 | $336.8M | $176.3M | ||
| Q1 25 | $325.5M | $127.1M | ||
| Q4 24 | $334.7M | $174.0M | ||
| Q3 24 | $231.3M | $150.6M | ||
| Q2 24 | $256.0M | $480.7M |
| Q1 26 | $530.1M | — | ||
| Q4 25 | $542.1M | $-80.0M | ||
| Q3 25 | $537.7M | $9.2M | ||
| Q2 25 | $532.2M | $151.3M | ||
| Q1 25 | $517.4M | $144.2M | ||
| Q4 24 | $517.8M | $255.0M | ||
| Q3 24 | $400.2M | $346.8M | ||
| Q2 24 | $388.4M | $432.4M |
| Q1 26 | $605.0M | — | ||
| Q4 25 | $612.9M | $1.5B | ||
| Q3 25 | $613.2M | $1.2B | ||
| Q2 25 | $608.9M | $1.3B | ||
| Q1 25 | $590.9M | $1.3B | ||
| Q4 24 | $592.2M | $1.5B | ||
| Q3 24 | $477.3M | $1.5B | ||
| Q2 24 | $443.6M | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $9.9M | $-99.8M | ||
| Q3 25 | $7.0M | $-91.4M | ||
| Q2 25 | $14.4M | $-108.3M | ||
| Q1 25 | $9.4M | $-166.5M | ||
| Q4 24 | $7.1M | $-79.3M | ||
| Q3 24 | $9.2M | $-67.0M | ||
| Q2 24 | $10.7M | $-77.0M |
| Q1 26 | — | — | ||
| Q4 25 | $6.1M | $-100.8M | ||
| Q3 25 | $2.9M | $-92.7M | ||
| Q2 25 | $10.2M | $-110.7M | ||
| Q1 25 | $6.0M | $-167.8M | ||
| Q4 24 | $4.4M | $-79.5M | ||
| Q3 24 | $5.9M | $-68.6M | ||
| Q2 24 | $8.0M | $-79.0M |
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | -48.6% | ||
| Q3 25 | 2.8% | -58.0% | ||
| Q2 25 | 10.1% | -66.5% | ||
| Q1 25 | 6.0% | -120.5% | ||
| Q4 24 | 4.4% | -48.3% | ||
| Q3 24 | 6.8% | -49.2% | ||
| Q2 24 | 9.7% | -53.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 0.5% | ||
| Q3 25 | 3.9% | 0.8% | ||
| Q2 25 | 4.1% | 1.5% | ||
| Q1 25 | 3.3% | 1.0% | ||
| Q4 24 | 2.6% | 0.1% | ||
| Q3 24 | 3.7% | 1.2% | ||
| Q2 24 | 3.2% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 32.34× | — | ||
| Q3 25 | 5.92× | — | ||
| Q2 25 | 2.73× | — | ||
| Q1 25 | 3.21× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDYN
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
